Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
Report Code : A02925 | Category : Life Sciences
Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is ...
Report Code : A03515 | Category : Life Sciences
The global recombinant vaccines market was valued at $8.1 billion in 2021, and is projected to reach $24.7 billion by 2031, growing at a CAGR of 11.4% from 2022 to 2031.
Report Code : A17605 | Pages : 258 | Category : Life Sciences
The global human recombinant insulin market was valued at $27.6 billion in 2023, and is projected to reach $34.7 billion by 2033, growing at a CAGR of 2.4% from 2024 to 2033.
Report Code : A281792 | Pages : 300 | Category : Life Sciences
